Archer Materials Limited
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Semi-annual Revenue
•
in mil. unless spec.Semi-annual Earnings Per Share
•
in mil. unless spec.Semi-annual Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Simon Ruffell
- Full Time Employees
- 8
- Sector
- Electronic technology
- Industry
- Semiconductors
- Address
- Lot Fourteen Adelaide SA Australia 5000
- IPO Date
- Jul 9, 2007
- Website
- archerx.com.au
- Similar Companies
- Business
- Archer Materials Limited is an Australian deep technology enterprise engaged in developing and commercializing advanced semiconductor innovations for quantum computing and medical diagnostics. The company’s primary focus includes its unique 12CQ qubit processor chip, a carbon-based technology engineered for operation at room temperature, aiming to integrate scalable quantum computing into modern electronic devices. Recent advancements have demonstrated successful electrical control and readout of quantum information from this device. Concurrently, Archer is developing a graphene-based lab-on-a-chip biochip, designed for ultra-sensitive, rapid, and cost-effective medical diagnostic applications. This biochip is initially targeting precise potassium level monitoring for chronic kidney disease patients, facilitating at-home or point-of-care testing. Notable progress includes miniaturizing the biochip's graphene field-effect transistor design and confirming its compatibility with silicon devices through a partnership with IMEC, moving towards a prototype and future clinical trials. Archer Materials also recently expanded its strategic partnerships, collaborating with Emergence Quantum to accelerate quantum technology development and with CSIRO on quantum machine learning for fraud detection. The company, which originated as Archer Exploration Limited before adopting its current name in October 2019, was founded in 2007 and operates from Adelaide, Australia.
Company News
Nine Mile Metals signs market-making and media agreements
Percheron Therapeutics targets one of oncology’s toughest problems: Why immunotherapy still falls short
Cyprium board signs off on Nifty cathode restart, clearing path to mid-2026 production
Archer advances towards single-qubit readout with key device milestone
Orthocell advances Remplir™ prostate surgery opportunity as Australian use surpasses 100 cases
Small Cap Watch: XSO extends declines, but there are company highlights
Archer and EPFL Co-Develop a Single Chip Integrated Pulsed Electron Spin Resonance Microsystem
Archer Materials ushers in use of quantum computing in mobile devices with latest 12CQ chip breakthrough
Archer Materials spinout ChemX Materials floats on the local share market
Archer Materials shares surge after integrating single atom-thick graphene on a silicon wafer
Archer Materials' “special year” sets stage for increasing role in quantum computing
Imugene and Archer Materials benefit from S&P Dow Jones Indices rebalance
Archer Materials develops sensing pathways to detect genetic information for biochip technology
Archer Materials flags priority offer under ChemX IPO
Archer Materials to collaborate with AIML on quantum semiconductor development
Archer Materials' deep tech could be game-changing for two key tech sectors
Archer Materials giving investors exposure to deep-tech
Archer Materials passes key milestone in early-stage assembly of biochip components
Archer Materials raises A$15 million in heavily backed SPP
Archer Materials closing SPP early after exceeding expectations to raise A$10 million